Press Releases scPharmaceuticals Inc.

Equities

SCPH

US8106481059

Real-time Estimate Cboe BZX Other stock markets 12:32:38 2024-06-12 pm EDT			5-day change	1st Jan Change
4.22 ^USD	+2.68%		-5.63%	-33.17%

May. 14	Transcript : ScPharmaceuticals Inc., Q1 2024 Earnings Call, May 14, 2024
May. 14	ScPharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

ScPharmaceuticals to Present at the Jefferies Global Healthcare Conference	May. 29	AQ
ScPharmaceuticals Inc. Reports First Quarter 2024 Financial Results and Provides Business Update	May. 14	AQ
ScPharmaceuticals to Present at the H.C. Wainwright 2nd Annual BioConnect Investor Conference	May. 13	AQ
ScPharmaceuticals to Announce First Quarter 2024 Financial Results on Tuesday, May 14, 2024	May. 07	AQ
ScPharmaceuticals Announces First Participant Enrolled in Pivotal Pharmacokinetic Study of FUROSCIX Auto-Injector Injection	Apr. 25	AQ
ScPharmaceuticals Announces First Participant Enrolled in Pivotal Pharmacokinetic Study of FUROSCIX Auto-Injector (furosemide 80mg/mL) Injection	Apr. 24	AQ
ScPharmaceuticals Inc. Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Business Update	Mar. 13	AQ
ScPharmaceuticals to Announce Fourth Quarter and Full-Year 2023 Financial Results on Wednesday, March 13, 2024	Mar. 06	AQ
ScPharmaceuticals to Participate in Two Upcoming Investor Conferences	Feb. 28	AQ
ScPharmaceuticals Announces Preliminary Unaudited Q4 and Full-Year 2023 Net FUROSCIX® Revenue	Jan. 04	AQ
ScPharmaceuticals Inc. Reports Third Quarter 2023 Financial Results and Provides Business Update	Nov. 08	AQ
ScPharmaceuticals to Announce Third Quarter 2023 Financial Results on Wednesday, November 8, 2023	Nov. 01	AQ
ScPharmaceuticals to Participate in Two Upcoming Investor Conferences	23-10-31	AQ
ScPharmaceuticals Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	23-10-05	AQ
ScPharmaceuticals Announces Positive Feedback from Two FDA Meetings on Key Long-Term Growth Initiatives	23-09-19	AQ
ScPharmaceuticals to Present at the H.C. Wainwright 25th Annual Global Investment Conference	23-09-05	AQ
ScPharmaceuticals Inc. Reports Second Quarter 2023 Financial Results and Provides Business Update	23-08-10	AQ
ScPharmaceuticals to Announce Second Quarter 2023 Financial Results on Thursday, August 10, 2023	23-08-03	AQ
ScPharmaceuticals Announces Positive Type C Meeting Feedback from FDA on Potential Heart Failure Class IV Indication Expansion	23-08-01	AQ
ScPharmaceuticals Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(4)	23-07-20	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases scPharmaceuticals Inc.

Equities

SCPH

US8106481059

Press Releases

Filters